Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035217 · ClinicalTrials.gov registry record
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00035217 is a clinical trial that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00035217 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination
Trial Details
| Field | Value |
|---|
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035217
The ClinicalTrials.gov registry entry for NCT00035217 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00035217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035217 about?
NCT00035217 is a clinical study titled "Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program". There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe th...
What is the current status of trial NCT00035217?
This trial is currently completed.
Who is sponsoring clinical trial NCT00035217?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.